학술논문

Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial
Document Type
Article
Source
In The Lancet Rheumatology June 2023 5(6):e341-e350
Subject
Primary Research
Articles
Language
ISSN
2665-9913